patients asthma chronic obstructive pulmonary disease addition beta2agonists laba glucocorticosteroids gcs results better control increasing dose gcs smooth muscle cells fibroblasts apparent underlying mechanism involves ability labas activate glucocorticoid receptor gr present study investigates effects formoterol form salmeterol salm budesonide bud gr activation bronchial epithelial cells tumour necrosis factor release gr nuclear translocation reporter gene activity bud form inhibited release NUMBER combination drugs clinically relevant concentrations inhibited release NUMBER unstimulated levels similar inhibition obtained combining bud salm ability form inhibit synthesis altered small interfering depletion gr form gr translocation cell nucleus addition form did activate reporter gene activity salm tested contrast clear effect bud concluded bronchial epithelial cells inhibition granulocytemacrophage colonystimulating factor synthesis formoterol salmeterol does act previously demonstrated glucocorticoid mechanisms suggesting alternative pathway cells long acting factor alpha stimulated colony stimulating gm csf gr regulated gm csf gm csf gm csf rna mediated salm induced gr regulated granulocyte macrophage receptor related